Study highlights long-term survival & side effect issues of adjuvant breast cancer therapy
New data published in the Journal of Clinical Oncology show ELLENCE® (epirubicin hydrochloride injection) based chemotherapy regimen has survival benefits with low risk of adverse cardiac events
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.